BioLum Receives NIH Award to Extend its Biomarker Platform to Cardiovascular Disease

Written By Jack R
 

BioLum has been awarded a Small Business Technology Transfer (STTR) grant ($251,943) from the National Institutes of Health (NIH) to conduct research and development on a chemiluminescent assay and device for monitoring Vascular Endogenous Nitric Oxide.

 
Jack R
Previous

BioNTX iC³ Summit Rising Stars
Next

5 Top Pulmonology Solutions Impacting the Healthcare Sector